NEWS HOME

»

VACCINE

 

Trump expects Covid vaccine to be available for 'every American' by April

US President Donald Trump has said that the United States would produce enough coronavirus vaccine doses for "every American" by April 2021.... read..

---

 

Serum Institute all set to begin phase 3 trials of Covid-19 vaccine

Serum Institute of India (SII) is all set to begin phase three trials of the Covishield Vaccine developed by AstraZeneca and Oxford University at Sassoon General Hospital in Pune, the hospital administration said on Saturday.... read..

---

 

Expect to have enough COVID-19 vaccines for every American by April 2021: Trump

US President Donald Trump on Friday (local time) said that his administration expects to have enough doses of coronavirus vaccines for every American citizen by April 2021.... read..

---

 

30 COVID vaccine candidates being developed: Health Ministry

: Nearly 30 Covid vaccine candidates in pre-clinical and clinical stages are under development by pharmaceutical industry and academia in India. While three of them are in advanced stage of Phase I/II/III trials and 4 are in advanced pre-clinical developm... read..

---

 

Preparing for potential Covid-19 vaccine launch: Moderna CEO

US-based biotech firm Moderna is actively preparing for a potential commercial launch of mRNA-1273, its Covid-19 vaccine, the company's CEO has said.... read..

---

 

Trump administration releases plan to offer a COVID-19 vaccine to all Americans free of charge

The US government has unveiled a plan to offer a COVID-19 vaccine to all Americans free of charge as early as January.... read..

---

 

Russia's Vector says COVID-19 vaccine provides immunity lasting at least 6 months

Moscow [Russia], September 17 (ANI/Sputnik): The vaccine against COVID-19 developed by Russia's research center Vector does not provide life-long immunity, but guarantees immunity that will last at least six months, the head of the center's zoonotic disea... read..

---

 

Need to ensure access to COVID-19 diagnostics, therapeutics, vaccines is fair and equitable: Harsh Vardhan

Access to protection should not be a factor of the ability to pay and there is a need to ensure that access to COVID-19 diagnostics, therapeutics and vaccines is fair and equitable, Union Health Minister Harsh Vardhan said on Thursday.... read..

---

 

Free vaccine for Americans, but won't be widely available till '21 summer

A 57 page "playbook" just in from the US government outlines a comprehensive plan to make the COVID-19 vaccine available free to all Americans once it is proven safe and effective.... read..

---

 

Mask not more effective than vaccine, says Trump

Despite Robert Redfield, the director of the US Centers for Disease Control and Prevention, saying that wearing a mask would be more effective than a vaccine against the coronavirus, President Donald Trump said that the mask is "not more effective" than t... read..

---

 

COVID-19 vaccine could be distributed in US from October: Trump

US President Donald Trump on Wednesday (local time) said that the COVID-19 vaccine could be distributed across the United States starting October and close to a hundred million doses could be distributed by the end of 2020.... read..

---

 

Hopeful COVID-19 vaccine will be available in India next year: Harsh Vardhan

Union Health Minister Harsh Vardhan on Thursday said that he is hopeful that by the early next year, the vaccine will be available in India and added that Prime Minister Narendra Modi has handled Covid-19 "meticulously."... read..

---

 

Russia to supply 100 million doses of COVID-19 vaccine to India's Dr. Reddy's Laboratories

The Russian Direct Investment Fund on Wednesday confirmed reaching an agreement to supply 100 million doses of Russian COVID-19 vaccine Sputnik V to India's Dr. Reddy's Laboratories.... read..

---

 

Dr Reddy's, RDIF to supply 100 million doses of Sputnik V vaccine to India

Dr Reddy's Laboratories and Russian Direct Investment Fund (RDIF) have agreed to cooperate on clinical trials and distribution of Sputnik V vaccine in India.... read..

---

 

CSIR collaborates with Aurobindo Pharma to develop COVID-19 vaccines

The Council of Scientific and Industrial Research (CSIR) and Aurobindo Pharma Limited on Tuesday announced a collaboration to develop vaccines for COVID-19.... read..

---

 

Russia to supply 100 million doses of Sputnik V vaccine to Dr Reddy's

The Russian Direct Investment Fund (RDIF) and Dr Reddy's Laboratories Limited, a global pharmaceutical company headquartered in India, have agreed to cooperate on clinical trials and distribution of Sputnik V Covid-19 vaccine in India, Russia's sovereign ... read..

---

 

DCGI gives nod to Serum Institute to restart phase 2,3 trials for COVID-19 vaccine

The Drugs Controller General of India (DCGI) has allowed Serum Institute of India (SII) to restart its phase two and three clinical trials for COVID-19 vaccine after the pharma major submitted the recommendations of the Data Safety Monitoring Board (DSMB)... read..

---

 

Vaccines won't end pandemic quickly unless delivered equitably: Gates

Even as the world is rushing for solutions to fight Covid-19, developing and manufacturing vaccines will not end the pandemic quickly unless they are delivered equitably, warn Bill and Melinda Gates.... read..

---

 

UN chief calls for int'l solidarity to find vaccine accessible to all

United Nations Secretary-General Antonio Guterres called on the international community to get united and find a vaccine that is accessible to all.... read..

---

 

Over 300 volunteers get Russian COVID-19 vaccine, 14 pc have minor complaints

Moscow [Russia], September 15 (ANI/Sputnik): Over 300 volunteers have been inoculated during the post-registration trials of Russia's COVID-19 vaccine, dubbed Sputnik V, around 14 percent of them have reported fatigue, muscle pain or high body temperature... read..

---

 

Three COVID-19 vaccines at clinical trial stage in India: ICMR DG

Three COVID-19 vaccines are at a clinical trial stage in the country and two indigenous vaccine candidates have completed phase one trial, Indian Council of Medical Research (ICMR) DG Dr Balram Bhargava said on Tuesday.... read..

---

 

Spain to begin clinical trials of Johnson & Johnson COVID-19 vaccine on Monday

Spain's first trials of a coronavirus vaccine are scheduled to begin on Monday, Alberto Borobia, the chief of the clinical trials unit of the La Paz University Hospital in Madrid, said on Sunday.... read..

---

 

SII to resume Covid vaccine trials once DCGI gives nod (Ld)

Serum Institute of India (SII) said on Saturday it will resume trials in India once the Drugs Controller General of India (DCGI) grants it permission.... read..

---

 

AstraZeneca resumes Covid vaccine trials in UK

Clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed in the UK following confirmation by the Medicines Health Regulatory Authority (MHRA) that it was safe to do so.... read..

---

 

Suspension of AstraZeneca COVID-19 vaccine trials showed fallacy of approach: RDIF CEO

Russian Direct Investment Fund (RDIF) CEO Kirill Dmitriev on Saturday said that temporary suspension of AstraZeneca COVID-19 vaccine candidate trials clearly showed the "fallacy of the approach" when countries "exclusively rely on novel and untested platf... read..

---

 

COVID-19 vaccine likely by first quarter of 2021: Harsh Vardhan

The COVID-19 vaccine might be ready by the first quarter of 2021, Union Health Minister Dr Harsh Vardhan said on Sunday.... read..

---

 

Pfizer, BioNTech to expand Covid vaccine Phase 3 trial

US-based pharmaceutical major Pfizer and German biotech firm BioNTech have announced to expand the enrollment of their Phase 3 Covid-19 vaccine trial to up to approximately 44,000 participants, up from an initial recruitment goal of 30,000 individuals.... read..

---

 

Iran to soon start human trials for anti-coronavirus vaccine

Tehran [Iran], September 13 (ANI/Xinhua): Iranian medical scientists will soon start human trials for an anti-coronavirus vaccine after the stage of animal trials has passed, official news agency IRNA reported on Saturday.... read..

---